Anesth Analg 2002;94:552-557
© 2002 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Ketamine Suppresses Norepinephrine-Induced Inositol 1,4,5-Trisphosphate Formation Via Pathways Involving Protein Kinase C
Akira Kudoh, MD*,
Emiko Kudoh, MD ,
Hiroshi Katagai, MD*, and
Tomoko Takazawa, MD*
Departments of *Anesthesiology and Pediatrics, Hirosaki National Hospital, Hirosaki, Japan
Address correspondence and reprint requests to Akira Kudoh, MD, Department of Anesthesiology, Hirosaki National Hospital, 1 Tominocho, Hirosaki 036-8545, Aomori, Japan.
Inositol 1,4,5-trisphosphate (IP3) is not only involved in the physiologic regulation of excitation-contraction coupling, but could also play a role in cardiac pathophysiology. We investigated the mechanism of ketamine modulation of norepinephrine (NE)-induced IP3 formation in neonatal rat cardiomyocytes. Ketamine 1 and 10 µM significantly decreased the IP3 response to 1 µM NE by 27% and 43%, respectively. One micromolar TMB-8 (an intracellular calcium antagonist) produced 42% more decreases in IP3 production than produced by ketamine alone. One hundred micromolar anthranilic acid (a phospholipase A2 inhibitor) significantly decreased NE (1 µM)-induced IP3 formation, and the inhibition was further enhanced by ketamine. Ten micromolar U 73122 (a phospholipase C inhibitor) did not significantly affect NE-induced IP3 in the presence or absence of ketamine. One micromolar ketamine significantly inhibited staurosporine (a nonselective protein kinase C antagonist)-, bisindolylmaleimide (a selective protein kinase C antagonist)-, and wortmannin (a phosphatidylinositide 3-kinase antagonist)-stimulated IP3 formation. In conclusion, ketamine suppresses NE-induced IP3 production, and the inhibition is caused through pathways including protein kinase C and a decrease in intracellular Ca2+ concentrations.
IMPLICATIONS: Ketamine inhibits norepinephrine-induced inositol 1,4,5-triphosphate formation in a dose-dependent manner via pathways that involve protein kinase C and a decrease in intracellular Ca2+ concentrations.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Shiga, K. Minami, K. Segawa, Y. Uezono, M. Shiraishi, T. Sata, C. Yamamoto, and K. Sung-Teh
The Inhibition of Aortic Smooth Muscle Cell Proliferation by the Intravenous Anesthetic Ketamine
Anesth. Analg.,
November 1, 2004;
99(5):
1408 - 1412.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|